| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $691K | +331.9% |
| Cost of Revenue | $1.3M | +2321.8% |
| Gross Profit | -$641K | -710.5% |
| R&D Expense | $2.8M | +64.6% |
| SG&A Expense | $7.4M | +174.2% |
| Operating Income | -$18.7M | -189.8% |
| Interest Expense | $354K | -43.0% |
| Pre-tax Income | -$18.9M | -167.2% |
| Net Income | -$18.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | -27.0% |
| Short-term Investments | $6.4M | +46.3% |
| Accounts Receivable | $228K | +200.0% |
| Inventory | $415K | +120.7% |
| Current Assets | $9.3M | +21.8% |
| Total Assets | $11.1M | +19.6% |
| Current Liabilities | $2.5M | -83.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.0M | -180.2% |
| Capital Expenditures | $847K | +730.4% |
| Investing Cash Flow | -$2.9M | +36.0% |
| Financing Cash Flow | $14.1M | +23.1% |
| Free Cash Flow | -$12.9M | -192.9% |
| -168.4% |
| EPS (Basic) | -$2.36 | +69.8% |
| EPS (Diluted) | -$2.36 | +69.8% |
| Total Liabilities |
| $4.8M |
| -70.1% |
| Stockholders' Equity | $6.3M | +130.4% |